A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) in the Treatment of Acute Pain After Hip Replacement Surgery Compared With Oxycodone and Placebo Followed by a Voluntary Open-Label Extension For Safety
This study has been terminated.
( This decision was made based on the slow recruitment and high discontinuation rates in the study. )
Study NCT00364533
Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received: August 11, 2006
Last Updated: September 25, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
